Senior insider sale
Chief Medical Officer at CORBUS PHARMACEUTICALS HOLDINGS, INC. — senior position signals high conviction
$242.8K
26.36K shares
What this filing means
SMETHURST DOMINIC plans to sell 26.36K shares of CORBUS PHARMACEUTICALS HOLDINGS, INC. valued at approximately $242.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/27/2026ACC: 0001972481-26-000237
Officer· Chief Medical Officer
Since Mar 2026
26.36K
Shares to sell
$242.8K
Approx. market value
23.02K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
Restricted Stock Units
Equity Compensation
6/30/2026
7KRestricted Stock Units
Equity Compensation
2/27/2026
6.40KRestricted Stock Units
Equity Compensation
1/31/2026
3.52KRestricted Stock Units
Equity Compensation
2/27/2025
6.11KTotal acquired23.02K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Restricted Stock Units Equity Compensation | 7K | — |
2/27/2026 | Restricted Stock Units Equity Compensation | 6.40K | — |
1/31/2026 | Restricted Stock Units Equity Compensation | 3.52K | — |
2/27/2025 | Restricted Stock Units Equity Compensation | 6.11K | — |
| Total | 23.02K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.33K
Market value
$31.0K
7/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
23.02K
Market value
$211.8K
7/27/2026
Total
Units
26.36K
Value
$242.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/2/2026 | 3.33K | $31.0K | — | Completed |
| Planned — Approximate Date | ||||
7/27/2026 | 23.02K | $211.8K | Nasdaq | Planned |
| Total | 26.36K | $242.8K | ||